Daiwa Securities Group
DTIL icon

Daiwa Securities Group’s Precision BioSciences DTIL Stock Holding History

Daiwa Securities Group’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7
Closed – – 1334
2022
Q3 		$0 Hold
7
– – ﹤0.01% 1356
2022
Q2 		$0 Hold
7
– – ﹤0.01% 1378
2022
Q1 		$1K Hold
7
– – ﹤0.01% 1303
2021
Q4 		$2K Hold
7
– – ﹤0.01% 1278
2021
Q3 		$2K Buy
7
+3
+75% +$1.02K ﹤0.01% 1241
2021
Q2 		$1K Hold
4
– – ﹤0.01% 1188
2021
Q1 		$1K Hold
4
– – ﹤0.01% 1194
2020
Q4 		$1K Sell
4
-6
-60% -$1.47K ﹤0.01% 1173
2020
Q3 		$2K Hold
10
– – ﹤0.01% 1140
2020
Q2 		$2K Hold
10
– – ﹤0.01% 1159
2020
Q1 		$2K Hold
10
– – ﹤0.01% 1158
2019
Q4 		$4K Buy
+10
New +$3.14K ﹤0.01% 1124

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Daiwa Securities Group's DTIL Position: Q4 2022 in Review

Daiwa Securities Group sold out of Precision BioSciences (DTIL) in Q4 2022, closing a stake of 7 shares.

Daiwa Securities Group first reported a position in DTIL in Q4 2019 and held it in 12 quarters. The position peaked at $4K in Q4 2019. 100 funds tracked by Wall St. Rank hold DTIL as of Q4 2022.

  • Daiwa Securities Group reported no remaining Precision BioSciences position as of Q4 2022 after selling out during the quarter.
  • Daiwa Securities Group sold 7 Precision BioSciences shares in Q4 2022.
  • Daiwa Securities Group first reported a position in Precision BioSciences in Q4 2019 and held it in 12 quarters.
  • Daiwa Securities Group's Precision BioSciences position peaked at $4K in Q4 2019.
  • 100 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2022.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.